PubRank

Arrhythmia Prediction Trial (APRET)

Clinical Trial ID NCT02175836

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02175836

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002 27.55
2 QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation 1978 3.32
3 Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol 2007 2.29
4 Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction. Eur Heart J 2009 1.92
5 Sudden cardiac death: exploring the limits of our knowledge. J Cardiovasc Electrophysiol 2001 1.48
6 Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk). Eur Heart J 2008 1.37
7 Prediction of long-term outcomes by signal-averaged electrocardiography in patients with unsustained ventricular tachycardia, coronary artery disease, and left ventricular dysfunction. Circulation 2001 1.23
8 Prediction of sudden cardiac death: appraisal of the studies and methods assessing the risk of sudden arrhythmic death. Circulation 2003 1.21
9 Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era. Eur Heart J 2005 1.20
10 The autonomic nervous system and sudden death. Eur Heart J 1998 1.17
11 Risk stratification for sudden cardiac death: current status and challenges for the future. Eur Heart J 2014 1.11
12 Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation. Circ Arrhythm Electrophysiol 2013 0.94
13 Arrhythmic sudden cardiac death: substrate, mechanisms and current risk stratification strategies for the post-myocardial infarction patient. Hellenic J Cardiol 2013 0.83
14 Implantable cardioverter defibrillator therapy activation for high risk patients with relatively well preserved left ventricular ejection fraction. Does it really work? Int J Cardiol 2012 0.83
15 Risk prediction by heart rate turbulence and deceleration capacity in postinfarction patients with preserved left ventricular function retrospective analysis of 4 independent trials. J Electrocardiol 2009 0.82
16 Decreased scale-specific heart rate variability after multiresolution wavelet analysis predicts sudden cardiac death in heart failure patients. Int J Cardiol 2011 0.81
17 A chronically implanted system for automatic defibrillation in active conscious dogs. Experimental model for treatment of sudden death from ventricular fibrillation. Circulation 1978 0.81
18 The rate-corrected QT interval calculated from 24-hour Holter recordings may serve as a significant arrhythmia risk stratifier in heart failure patients. Int J Cardiol 2011 0.79
19 A combined anatomic and electrophysiologic substrate based approach for sudden cardiac death risk stratification. Am Heart J 2013 0.78
20 Elevated nighttime heart rate due to insufficient circadian adaptation detects heart failure patients prone for malignant ventricular arrhythmias. Int J Cardiol 2013 0.78
21 Predictive value of programmed ventricular stimulation in patients with ischaemic cardiomyopathy: implications for the selection of candidates for an implantable defibrillator. Europace 2007 0.76
22 Ventricular arrhythmias: from the electrophysiology laboratory to clinical practice. Part II: potentially malignant and benign ventricular arrhythmias. Hellenic J Cardiol 2012 0.75
23 Ventricular arrhythmias: from the electrophysiology laboratory to clinical practice. Part I: malignant ventricular arrhythmias. Hellenic J Cardiol 2011 0.75
Next 100